0001225208-16-037271.txt : 20160801 0001225208-16-037271.hdr.sgml : 20160801 20160801203756 ACCESSION NUMBER: 0001225208-16-037271 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160728 FILED AS OF DATE: 20160801 DATE AS OF CHANGE: 20160801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edwards Lifesciences Corp CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP. DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP DATE OF NAME CHANGE: 20000203 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Verguet Patrick B CENTRAL INDEX KEY: 0001308771 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 161798710 MAIL ADDRESS: STREET 1: CHEMIN CHANTEBISE 19 CITY: COMMUNGNY STATE: V8 ZIP: 1291 4 1 doc4.xml X0306 4 2016-07-28 0001099800 Edwards Lifesciences Corp EW 0001308771 Verguet Patrick B ONE EDWARDS WAY IRVINE CA 92614 1 CVP, Europe Common Stock 2016-07-28 4 M 0 5000.0000 25.4800 A 133952.1610 D Common Stock 2016-07-28 4 S 0 5000.0000 115.0000 D 128952.1610 D Common Stock 2016-07-29 4 M 0 5000.0000 25.4800 A 133998.5766 D Common Stock 2016-07-29 4 S 0 5000.0000 114.7343 D 128998.5766 D Employee Stock Option (Right to Acquire) 25.4800 2016-07-28 4 M 0 5000.0000 0.0000 D 2011-05-13 2017-05-12 Common Stock 5000.0000 83000.0000 D Employee Stock Option (Right to Acquire) 25.4800 2016-07-29 4 M 0 5000.0000 0.0000 D 2011-05-13 2017-05-12 Common Stock 5000.0000 78000.0000 D This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This transaction was executed in multiple trades at prices ranging from $114.7301 to $114.76. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Ifigenia Protopappas, Attorney-in-fact 2016-08-01